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ABSTRACT
Objective: We report on 3 patients who underwent lapa-
roscopic antireflux procedures for persistent symptoms of
GERD after biopolymer injection.
Methods: Experienced laparoscopic surgeons completed
all 3 procedures laparoscopically. In 2 patients, there was
an extramural extravasation of the polymer outside and
adherent to the esophageal wall. In these patients, a par-
tial posterior fundoplication was used. The third patient,
who had the polymer material deposits removed preop-
eratively by endoscopic mucosal resection, underwent a
Nissen fundoplication.
Results: Postoperative recovery was uneventful in all
cases. At follow-up of 6 to 12 months, all patients were
symptom free, off medical therapy, and experiencing no
dysphagia.
Conclusion: Surgical therapy for patients after failed
biopolymer injection is safe and effective. The choice of
surgery may depend on whether the polymer mass can be
removed preoperatively.
Key Words: Enteryx®, Laparoscopic fundoplication, En-
doscopic mucosal resection, Reflux.
INTRODUCTION
Endoscopic treatment of gastroesophageal reflux disease
(GERD) has gained popularity over the last several years
as an alternative to long-term medications for patients
with confirmed GERD. All techniques attempt to augment
the antireflux barrier at the lower esophageal sphincter.
Some techniques, such as the Plicator and the Esophyx
attempt to create a partial fundoplication at the cardia,
while the Stretta procedure uses radiofrequency to create
intramural fibrosis and reduce transient lower sphincter
relaxation. Yet another class of therapies was based on
injection of biocompatible polymers into the distal esoph-
ageal wall to produce a mechanical effect of narrowing
the lumen and hoping to prevent acid reflux. Enteryx was
among the latter group and was approved by the US Food
and Drug Administration in April 2003. The treatment was
based on endoscopic injection of 8% ethyl vinyl alcohol
dissolved in dimethyl sulfoxide directly into the lower
esophageal sphincter region. The product is injected in a
liquid form and thickens into a permanent spongy lump.
Early clinical studies suggested that Enteryx might im-
prove symptom control and allow discontinuation or
reduction of pharmacotherapy for GERD in carefully
selected patients.1,2 While long-term studies were under-
way, a number of serious complications including 2
deaths were reported with its use, and the product was
quickly withdrawn from the market by Boston Scientific
the proprietary makers of Enteryx.3,4 Both deaths were
due to complications arising from injection of the polymer
outside the esophageal wall. In the few years that Enteryx
was clinically available, over 3800 patients underwent the
injection. No clear data exist that the patients who had the
therapy need to seek removal; however, several patients
with failed therapy are now seeking a surgical solution to
their chronic GERD problem. The surgical strategy for
treatment of these patients is poorly described. Two pre-
vious reports have utilized a Nissen fundoplication after
Enteryx failure.5,6 In one study, the polymer was excised
intraoperatively, but in the other study, the fate of the
polymer mass is not clear. Clearly, if left in place, the mass
effect of the polymer may increase the postoperative dys-
phagia in patients undergoing a full Nissen fundoplica-
tion. We have taken the position that patients who are
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CASE REPORTamenable to removal of the esophageal submucosal de-
posits with endoscopic mucosal resection (EMR) should
consider this before antireflux surgery. In those in whom
a preoperative CT scan shows extramural deposits, this is
not possible, and we should attempt to remove it intraop-
eratively or perform a partial posterior fundoplication. We
report on 3 patients treated with the above strategy by
experienced laparoscopic surgeons in 2 different institu-
tions.
CASE ONE
The first patient was a 26-year-old male who was referred
to the surgeon 3 months after being treated with Enteryx
injection (7 mL injected) for GERD due to recurrent symp-
toms. He required high doses of proton pump inhibitor
(PPI) therapy with a partial response.
A preoperative workup included upper gastrointestinal
endoscopy, which showed grade II esophagitis and a
small hiatal hernia. A new preoperative pH study and
manometry were not repeated because the patient re-
fused. Intraoperatively, evidence was present of extramu-
ral injection of Enteryx with marked inflammatory reac-
tions and fibrosis around the lower esophagus, posteriorly
and to the left side, with the Enteryx polymer mass clearly
identifiable outside the esophageal wall but very adherent
and encasing the posterior vagus. It was impossible to
dissect the polymer mass off the esophagus without risk of
perforation (Figures 1 and 2). The mass was separated
from the left crus and left in situ. An adequate length of
intraabdominal esophagus was obtained after careful hi-
atal and mediastinal dissection. To avoid the risk of post-
operative dysphagia because the Enteryx mass was left in
place, the decision was made to perform a partial poste-
rior fundoplication, including approximation of the crus
and fixation of the wrap on these (Figures 3 and 4). The
surgery was completed in one hour, and no intraoperative
complications occurred. The patient had a smooth post-
operative recovery. At 6-month follow-up, the patient was
asymptomatic, off medications, and the upper gastrointes-
tinal barium study showed the valve nicely in place.
CASE TWO
The second patient was a 36-year-old male who was
referred 6 months after Enteryx injection (8mL) with per-
sistent reflux symptoms that failed to respond completely
Figure 3. The picture shows how difficult trying to do complete
wrap.
Figure 1. The posterior vagus nerve encased by the Enteryx.
Figure 2. The Enteryx polymer mass adherent to the esophagus.
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showed excessive acid reflux with a Demester score of 29
on day 1 and 33 on day 2. An abdominal x-ray showed a
radio-opaque material at the level of the cardia. Endo-
scopic examination revealed relaxed cardia. The finding
during surgery was of mild inflammatory changes at the
gastroesophageal junction and a hard mass adherent to
the esophageal wall close to the fat pad and the angle of
His. Hiatal dissection was carried out in the usual manner
with no problems. Two centimeters of intraabdominal
esophageal length was achieved. The Enteryx material
was left attached to the esophagus. Both vagi where
identified. Complete mobilization of the stomach fundus
was done. A partial posterior fundoplication was per-
formed to avoid the risk of persistent postoperative dys-
phagia. The operative time was 45 minutes. The proce-
dure and postoperative recovery were uneventful. At one-
year follow-up after surgery, the patient was symptom
free, and upper gastrointestinal endoscopy showed com-
petent lower esophageal sphincter.
CASE THREE
The patient was a 46-year-old male with a 3-year history of
GERD symptoms on PPI. He was seen in the surgical clinic
12 months after Enteryx injections with recurrent reflux
symptoms. His symptoms were relieved by medical treat-
ment, but he did not want long-term medical therapy, and
that was the reason he chose the Enteryx injection initially.
Preoperatively, he underwent an upper gastrointestinal
endoscopy that showed no esophagitis or hiatal hernia.
The Enteryx material was bulging into the lumen of the
distal esophagus and was removed by endoscopic muco-
sal resection (EMR). The surgery was performed 3 months
later. Intraoperatively, no extramural foreign material was
seen, and there was no unusual thickening or fibrosis
around the gastroesophageal junction. A laparoscopic Nis-
sen fundoplication was performed with no complications.
The operative time was 52 minutes. Postoperative recov-
ery was uneventful. At 6-month follow-up, the patient was
symptom free and off medication.
DISCUSSION
This study reports on the surgical approach used in 3
patients with failed Enteryx therapy. As with previous
reports, we have found that extramural injection is asso-
ciated with significant fibrosis and the presence of mate-
rial adherent to the esophageal wall creating a mass effect.
Although it is preferable to remove the extramural poly-
mer completely, it may not be possible due to dense
adherence to the esophageal wall or adjoining structures,
such as the vagus nerve. In these patients, we recommend
a partial posterior fundoplication as a means of preventing
the possibility of postoperative dysphagia and need for
further intervention in a patient with already significant
fibrosis in the region.
Two previous articles have reported about the perfor-
mance of laparoscopic Nissen fundoplication after failed
Enteryx therapy. In one study,6 the black polymer material
was dissected off the esophageal wall and removed. In the
other study,5 3 patients had evidence of extramural mate-
rial causing severe fibrosis. While the text does not spe-
cifically state it, it appears that the authors were able to
remove all or part of the polymer before completing the
Nissen. In our 2 cases, removal of the polymer was
deemed dangerous due to the encasement of the vagal
trunk in one and close adherence to the esophageal wall
in the other.
The third patient in our series had a submucosal injection
primarily. In this case, we elected to have the polymer
deposits removed by the gastroenterologist using the en-
doscopic mucosal resection technique. This was unevent-
ful, and subsequently the patient underwent a standard
laparoscopic Nissen fundoplication. It is interesting that in
this case there were no significant fibrotic changes.
It is clear that while the Enteryx polymer was injected
under fluoroscopic control and the gastroenterologists
were trying hard to follow the recommended path to inject
it into the muscle layer, in practice this proved to be
difficult. We suspect that in many patients there was some
Figure 4. Completed Toupet fundoplication with wrap sutured
to the esophagus above the polymer.
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chest pain postinjection was a common one. Of interest,
the third patient in our series who mainly had submucosal
injection had no complaints of chest pain following the
injection but did not experience much symptom control.
Surgical studies have shown that both laparoscopic partial
posterior and Nissen fundoplications are effective long-
term therapies. While Nissen fundoplication may be asso-
ciated with slightly better symptom control, it is also as-
sociated with a higher incidence of postoperative
dysphagia and bloating. We use a laparoscopic Nissen
fundoplication as our primary antireflux operation of
choice, except in patients with severe esophageal dysmo-
tility or in revision of a previous fundoplication for dys-
phagia or gas bloat syndrome. We propose that a partial
fundoplication may be a prudent choice in patients in
whom a large polymer mass has to be left in situ either
extramurally or intramurally in the region of the distal
esophagus and included within the wrap. If, on the other
hand, the bulk of the polymer can be removed then a
laparoscopic Nissen fundoplication is the surgery of
choice.
CONCLUSION
Many more patients are likely to require antireflux surgery
for failed Enteryx therapy. The surgical strategy may be
dependent on the ability to remove some or all of the
polymer mass. If so, we recommend a Nissen fundoplica-
tion, but if not, a partial wrap may be the most prudent
approach to avoid postfundoplication symptoms of dys-
phagia and bloating brought on by the presence of an
8-mL to 10-mL mass inside a 360° wrap.
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